KEGG analysis of core targets showed that AR treatment of CRF involved a variety of signaling pathways related to tumors: pathways in cancer, AGE-RAGE, IL-17, TNF, Toll-like receptor, and HIF-1 pathways. This evidence concerns the gene IL17A and cancer.